Enochian Biosciences Inc.

NASDAQ: ENOB · Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 7:58 PM

Enochian Biosciences Statistics

Share Statistics

Enochian Biosciences has 63.7M shares outstanding. The number of shares has increased by 0% in one year.

63.7M
0%
0%
n/a
n/a
18,870
7.41%

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is -1.86 and the forward PE ratio is null. Enochian Biosciences's PEG ratio is -0.1.

-1.86
n/a
0
n/a
1.14
-13.6
-0.1
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Enochian Biosciences.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 0.07, with a Debt / Equity ratio of 0.03.

0.07
0.07
0.03
-0.05
-0.34
-80.73

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-3,665,916.86
22
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -72.69% in the last 52 weeks. The beta is 0.94, so Enochian Biosciences's price volatility has been higher than the market average.

0.94
-72.69%
0.97
1.11
77.82
254,603

Income Statement

n/a
-121.86K
-81.64M
-80.65M
-79.52M
-79.64M
-0.84
Full Income Statement

Balance Sheet

The company has 220.47K in cash and 3.79M in debt, giving a net cash position of -3.57M.

220.47K
3.79M
-3.57M
-324.68M
58,018.1B
-11,355.2B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.97M and capital expenditures -70.43K, giving a free cash flow of -11.04M.

-10.97M
-70.43K
-11.04M
-0.11
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

ENOB does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ENOB.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-8.75
1